Souhaitez-vous accéder aux communiqués récents ?

23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened balance sheet Growth reflects both organic clinic initiatives and acquisition...

Issued on behalf of Eagle Nuclear Energy Corp. A sector analysis of the nuclear-fuel and uranium complex — the energy source the world spent decades retreating from, and is now racing back toward to...

NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Teamshares, a tech-enabled acquiror of SMEs, previously announced its completed business combination with Live Oak Acquisition Corp. V (NASDAQ: LOKV) on...

GREENVILLE, S.C., June 22, 2026 (GLOBE NEWSWIRE) -- Courser, a leading managed IT services platform, today announced the appointments of Chad Polich as Chief Financial Officer (CFO) and William...

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera’s plan to...

BANGKOK, June 22, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”) today announced that NewGen’s total outstanding shares now stand at 10,073,535 following...

NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial results for the fiscal quarter ended May 31, 2026, on...

MITOLINE®-Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in a Synergistic Virtual Screening Campaign for selected Transporter Targets Neve Yarak, Israel, June ...

The case alleges that Grail’s top executives made false and/or misleading statements to investors.

Vancouver, Canada, June 22, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development...